BioMark Diagnostics Inc.
BUX
Rank in Stocks
#26720
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Share Price
$0.33433516
Last synced: 2026-10-20
Market Cap
$35.60M
Change (1 day)
-3.08%
Change (1 year)
36.77%
Country
CA
Trade BioMark Diagnostics Inc. (BUX)
Category
Healthcare
Stock price history for BioMark Diagnostics Inc. (BUX)
Highest end of day price: $0.38 on 2026-10-01
Lowest end of day price: $0.35 on 2015-03-01
Lowest end of day price: $0.35 on 2015-03-01
Stock price history of BioMark Diagnostics Inc. from 2015 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 6.73% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $696.42 | 24.81% |
US
|
|
| $232.94 | 5.51% |
US
|
|
| $416.94 | 123.10% |
US
|
|
| $22.06 | 54.01% |
CN
|
|
| $177.89 | 22.11% |
US
|
